Peroxisome proliferator-activated receptors: A key link between lipid metabolism and cancer progression
Clinical Nutrition · 2024-02 · 43 (2) · 332-345
DOI: 10.1016/j.clnu.2023.12.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Nutrition, 2024-02. Verfasst von Yunkuo Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Hospital of Jilin University, Changchun 130021, China. Hauptthemen laut MEDLINE: Peroxisome Proliferator-Activated Receptors, Neoplasms. Die Arbeit wurde bisher 143-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Lipids represent the essential components of membranes, serve as fuels for high-energy processes, and play crucial roles in signaling and cellular function. One of the key hallmarks of cancer is the reprogramming of metabolic pathways, especially abnormal lipid metabolism. Alterations in lipid uptake, lipid desaturation, de novo lipogenesis, lipid droplets, and fatty acid oxidation in cancer cells all contribute to cell survival in a changing microenvironment by regulating feedforward oncogenic signals, key oncogenic functions, oxidative and other stresses, immune responses, or intercellular communication. Peroxisome proliferator-activated receptors (PPARs) are transcription factors activated by fatty acids and act as core lipid sensors involved in the regulation of lipid homeostasis and cell fate. In addition to regulating whole-body energy homeostasis in physiological states, PPARs play a key role in lipid metabolism in cancer, which is receiving increasing research attention, especially the fundamental molecular mechanisms and cancer therapies targeting PPARs. In this review, we discuss how cancer cells alter metabolic patterns and regulate lipid metabolism to promote their own survival and progression through PPARs. Finally, we discuss potential therapeutic strategies for targeting PPARs in cancer based on recent studies from the last five years.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The First Hospital of Jilin University, Changchun 130021, China.
- Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun 130021, China.
- Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun 130021, China. Electronic address: wangys@jlu.edu.cn.
- Department of Urology, The First Hospital of Jilin University, Changchun 130021, China. Electronic address: hlzhou@jlu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, Y., Pan, Y., Zhao, X., Wu, S., Li, F., Wang, Y., Liu, B., Zhang, Y., Gao, X., Wang, Y., & Zhou, H. (2024). Peroxisome proliferator-activated receptors: A key link between lipid metabolism and cancer progression. Clinical Nutrition, 43(2), 332-345. https://doi.org/10.1016/j.clnu.2023.12.005
Vancouver
Li Y, Pan Y, Zhao X, Wu S, Li F, Wang Y, et al. Peroxisome proliferator-activated receptors: A key link between lipid metabolism and cancer progression. Clinical Nutrition. 2024;43(2):332-345. doi:10.1016/j.clnu.2023.12.005
BibTeX
@article{Li2024,
author = {Li, Yunkuo and Pan, Yujie and Zhao, Xiaodong and Wu, Shouwang and Li, Faping and Wang, Yuxiong and Liu, Bin and Zhang, Yanghe and Gao, Xin and Wang, Yishu and Zhou, Honglan},
title = {Peroxisome proliferator-activated receptors: A key link between lipid metabolism and cancer progression},
journal = {Clinical Nutrition},
year = {2024},
volume = {43},
number = {2},
pages = {332--345},
doi = {10.1016/j.clnu.2023.12.005}
}
EUVIMED